Total Payments
$97,966
2024 Payments
$3,385
Companies
35
Transactions
256
Medicare Patients
245
Medicare Billing
$34,443
Payment Breakdown by Category
Other$90,000 (91.9%)
Food & Beverage$6,543 (6.7%)
Consulting$1,413 (1.4%)
Education$10.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $90,000 | 1 | 91.9% |
| Food and Beverage | $6,543 | 252 | 6.7% |
| Consulting Fee | $1,413 | 2 | 1.4% |
| Education | $10.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $90,024 | 2 | $0 (2021) |
| TG Therapeutics, Inc. | $2,084 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,505 | 55 | $0 (2024) |
| EMD Serono, Inc. | $994.34 | 29 | $0 (2024) |
| ABBVIE INC. | $525.35 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $464.75 | 36 | $0 (2024) |
| Celgene Corporation | $429.90 | 36 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $263.34 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $249.60 | 2 | $0 (2022) |
| ARGENX US, INC. | $136.92 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,385 | 90 | TG Therapeutics, Inc. ($1,757) |
| 2023 | $1,583 | 70 | EMD Serono, Inc. ($353.05) |
| 2022 | $1,719 | 71 | Novartis Pharmaceuticals Corporation ($341.20) |
| 2021 | $947.18 | 21 | Novartis Pharmaceuticals Corporation ($614.62) |
| 2020 | $90,099 | 2 | Biogen, Inc. ($90,000) |
| 2019 | $231.71 | 2 | Sunovion Pharmaceuticals Inc. ($121.32) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Neurology | ||||||
| 11/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $565.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Merz Pharmaceuticals, LLC | AMPYRA (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Multiple Sclerosis | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.96 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.31 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.19 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug), AMPYRA | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Parkinson's Disease | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Neurology | ||||||
| 10/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $35.93 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.87 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.53 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $20.23 | General |
| Category: Neurology | ||||||
| 10/02/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Neurology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Neurology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: Neurology | ||||||
| 09/25/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 113 | 142 | $40,116 | $15,493 |
| 2022 | 2 | 86 | 111 | $35,511 | $13,441 |
| 2021 | 3 | 46 | 50 | $14,020 | $5,509 |
Total Patients
245
Total Services
303
Medicare Billing
$34,443
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 73 | $19,710 | $8,122 | 41.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 33 | 33 | $13,530 | $4,781 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 36 | $6,876 | $2,590 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 47 | 72 | $19,488 | $7,651 | 39.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 39 | 39 | $16,023 | $5,790 | 36.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 20 | 20 | $8,200 | $3,026 | 36.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 18 | $4,860 | $2,151 | 44.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 11 | 12 | $960.00 | $332.64 | 34.7% |
About Dr. Jason Poon, M.D
Dr. Jason Poon, M.D is a Neurology healthcare provider based in Kirkland, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1417319658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Poon, M.D has received a total of $97,966 in payments from pharmaceutical and medical device companies, with $3,385 received in 2024. These payments were reported across 256 transactions from 35 companies. The most common payment nature is "Grant" ($90,000).
As a Medicare-enrolled provider, Poon has provided services to 245 Medicare beneficiaries, totaling 303 services with total Medicare billing of $34,443. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Kirkland, WA
- Active Since 03/27/2016
- Last Updated 09/16/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1417319658
Products in Payments
- BRIUMVI (Drug) $2,023
- KESIMPTA (Drug) $807.83
- ZEPOSIA (Drug) $429.90
- BOTOX (Biological) $404.89
- GILENYA (Drug) $400.89
- MAVENCLAD (Drug) $353.05
- Austedo XR (Drug) $344.60
- Xeomin (Biological) $211.22
- MAYZENT (Drug) $179.35
- Mavenclad (Drug) $150.81
- INBRIJA (Drug) $146.26
- APTIOM (Drug) $121.32
- VYVGART (Drug) $107.06
- NUPLAZID (Drug) $76.05
- NURTEC ODT (Drug) $75.08
- Leqembi (Drug) $72.65
- Hizentra (Biological) $68.97
- UBRELVY (Drug) $67.97
- PANZYGA (Biological) $59.16
- Ocrevus (Biological) $55.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Kirkland
Dr. Arash Fazl, M.d. , Ph.d, M.D. , PH.D
Neurology — Payments: $39,994
Neurology $39,994
James Song, M.d, M.D
Neurology — Payments: $30,735
Neurology $30,735
Dr. Zeyad Morcos, Md, MD
Neurology — Payments: $14,243
Neurology $14,243
Dr. Casey Nazor, M.d, M.D
Neurology — Payments: $8,976
Neurology $8,976
Dr. Alida Griffith, Md, MD
Neurology — Payments: $8,302
Neurology $8,302
Dr. Daniel Burdick, Md, MD
Neurology — Payments: $6,269
Neurology $6,269